Holiday season sales shine, Lululemon (LULU.US) raises Q4 revenue and profit guidance
Lululemon Athletica announced on Monday that it is currently expecting revenue for the fourth quarter of 2024 to be between $35.60 billion and $35.80 billion (an increase of 11% to 12% year-over-year), with diluted earnings per share expected to be between $5.81 and $5.85.
Lululemon Athletica (LULU.US) announced on Monday that it expects fourth quarter revenue for 2024 to be between $35.60 billion and $35.80 billion, an increase of 11% to 12% compared to the previous forecast of $34.75 billion to $35.10 billion, and higher than the analyst consensus of $34.70 billion.
At the same time, Lululemon expects diluted earnings per share for the fourth quarter to be between $5.81 and $5.85, higher than the previous forecast of $5.56 to $5.64, and also above the analyst consensus of $5.66. The company also expects gross margins for the fourth quarter to increase by 30 basis points compared to the same period last year, previously forecasted to decline by 20 to 30 basis points; and anticipates sales, general, and administrative expenses for the fourth quarter to decrease by 80 to 90 basis points compared to the same period last year.
Lululemon CEO Meghan Frank stated, "During the holiday season, our customers have responded well to our products, allowing us to raise our performance expectations for the fourth quarter."
Boosted by this news, as of the time of writing, Lululemon's pre-market stock in the U.S. rose nearly 3% on Monday.
Related Articles

HK Stock Market Move | HENLIUS (02696) is currently up nearly 9%. The company's three innovative solid tumor drugs have been accepted for IND at the same time.

Expand Gaode's global model and establish a physical business department to launch related product applications.

HK Stock Market Move | Gambling stocks generally weaken, GALAXY ENT (00027) dropped nearly 3%, Macau's gambling revenue in December last year fell short of expectations.
HK Stock Market Move | HENLIUS (02696) is currently up nearly 9%. The company's three innovative solid tumor drugs have been accepted for IND at the same time.

Expand Gaode's global model and establish a physical business department to launch related product applications.

HK Stock Market Move | Gambling stocks generally weaken, GALAXY ENT (00027) dropped nearly 3%, Macau's gambling revenue in December last year fell short of expectations.

RECOMMEND

Hong Kong Listed Companies’ Return To A Shares Heats Up As New “H To Shenzhen A” Case Emerges
05/01/2026

What Do The Top Ten Biopharma IPOs Of 2025 Tell Us?
05/01/2026

Asia’s Stock Markets Deliver A Strong 2025: Korea Soars 76%, Japan Tops Bubble‑Era Peak, Indonesia Records Best Year In 11 Years
05/01/2026


